Why Cannabis Beverages Need Their Own Category

The word "cannabis" today covers two products that have almost nothing in common. A 100-milligram edible and a 5-milligram sessionable beverage share a label, a regulatory framework, and often a retail shelf. They do not share a formulation, a use occasion, a consumer, or an outcome. Treating them as the same category is a brand problem the cannabis industry created for itself, and it is the single biggest thing slowing the functional case for low-dose cannabis beverages.

The Two-Product Problem

A 100mg edible is a high-dose product formulated for a specific consumer need, often a medical one. It belongs in a dispensary, served by knowledgeable staff to a consumer who knows exactly what they are buying and why. The effects last hours, the experience is intense, and the use case is purposeful.

A 5mg cannabis-infused beverage is a different product entirely. It is closer in effect profile to a glass of wine than to an edible. The dose is mild, the onset is fast, the offset is fast, and the experience is controllable enough to drink at a dinner party without disrupting the evening. The consumer is different. The use occasion is different. The formulation rationale is different. The retail environment that should serve it is different.

Both products are legitimate. Both serve real consumer needs. They are not, by any operational measure, the same thing.

The Cost of Conflation

When a category lets two unlike products share a single label, three groups pay the cost.

Consumers cannot tell the products apart. A first-time buyer reaching for a sessionable beverage may pick up a multi-serve, high-dose format with similar packaging and have an experience they were not expecting. That confusion travels with them into every future cannabis purchase.

Retailers cannot merchandise the products correctly. The 5mg beverage belongs in the cooler next to the other functional drinks. The 100mg edible does not. Shoving them into the same set tells the consumer the products are equivalent and trains the buyer to be cautious about both.

Regulators write rules that treat the two as identical because the industry has not made the distinction clear to them. Caps, restrictions, and channel limits get applied to the entire category when most of them only make sense for the high-dose end of it.

None of that is the regulator's fault. It is a marketing failure the industry has been slow to address.

The Operator Move

The brands that will win the functional-beverage chapter of cannabis are the ones treating taxonomic clarity as a brand-building act. That means naming the product as a functional beverage, not as cannabis-in-a-can. It means writing the label and the packaging for a sessionable consumer, not a dispensary regular. It means choosing distribution channels, price points, and merchandising adjacencies that signal "this is a drink" rather than "this is a cannabis product that happens to be a drink."

The category will sort itself out at the regulatory level eventually. The brand work has to happen now, by operators willing to be specific about what their product is and is not.

~

This argument is part of an ongoing series, The Future is Fluid, at The Proof is in the Pour.